U.S. President Donald Trump has signed an executive order aimed at expanding the use of artificial intelligence (AI) in pediatric cancer research. The order provides an additional $50 million in research grants to accelerate progress in finding cures for childhood cancers, according to White House officials.
This move builds on the National Cancer Institute’s (NCI) Childhood Cancer Data Initiative, a decade-long, $500 million program launched in 2019 to collect and share vital data on pediatric cancers. Michael Kratsios, director of the White House Office of Science and Technology Policy, highlighted that childhood cancer remains the leading cause of disease-related deaths among children in the United States, with cases rising more than 40% since 1975.
Kratsios noted that advances in AI can now be harnessed to sharpen diagnoses, improve clinical trials, fine-tune treatment strategies, and enhance prevention methods. Data gathered through the NCI initiative is expected to empower researchers with new tools to tackle the complexity and diversity of pediatric cancers.
In addition to the $50 million in grants, the National Institutes of Health (NIH) will double its commitment by investing another $50 million. This funding aims to attract leading scientific teams through competitive research opportunities. Further investments are also anticipated to strengthen ongoing initiatives.
The announcement comes despite Trump’s 2026 budget proposal, which suggested a 37% cut to the NCI budget. Lawmakers in both the House and Senate, however, have pushed back against these cuts, and budget negotiations remain ongoing.
Globally, the World Health Organization reports that around 400,000 children and adolescents are diagnosed with cancer each year. While advances in adult cancer research have surged with AI, pediatric cancer research has lagged due to challenges like cancer rarity, diversity, and ethical concerns over patient data protection.
By reinforcing funding and leveraging AI, the administration aims to close this gap and accelerate life-saving innovations in childhood cancer treatment.


U.S. Warns Allies Over Alleged Chinese AI IP Theft Linked to DeepSeek
China vs. NASA: The New Moon Race and What's at Stake by 2030
NASA and Roscosmos Chiefs Meet in Florida to Discuss Moon and ISS Cooperation
US Freezes $344M in Crypto Linked to Iran Amid Escalating Sanctions
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
USDA Plans to Expand Farmer Surveys to Improve Crop Report Accuracy
Federal and State Authorities Conduct Widespread Fraud Raids Across Minnesota
US Ties UN Funding to Reforms and Efforts to Counter China’s Influence
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
King Charles Reaffirms UK-US Alliance Amid Global Tensions
Taiwan Court Fines Tokyo Electron Unit $4.78M in Major TSMC Trade Secrets Case
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil 



